$CEI,,, Camber Energy, Inc. (CEI) shares saw a recent bid

New Post Public Reply Private Reply Replies (0) Message Board
OldSaltDawg
491
$CEI,,,

Camber Energy, Inc. (CEI) shares saw a recent bid of $0.25 and 918.66TH shares have exchanged hands in the recent trading session, yielding a 2.51% gain over the past week. The stock price increased 4.52% or $-0.02 versus $0.23 at the end of the prior session. This change led market cap to move at $6.39M, putting the price -95.17% below the 52-week high and 53.13% above the 52-week low. The company’s stock has a normal trading capacity of 744.45K shares while the relative volume is 1.23.

By historical standards, Camber Energy, Inc. remains a cheap stock. The company’s current price-earnings ratio amounts above the average P/E ratio of 20.90 times earnings. Over the short term, some market observers may have noticed that Camber Energy, Inc. has a 12.04% short float with 15 days to cover. It becomes significant when you consider how many shares are shorted versus the average daily volume, means how many days to cover those short shares at that volume. Camber Energy, Inc. has far performed well this year, with the share price down -80.24% since January. Over the past 2 quarters, the stock is down -79.92%, compared with a fall of nearly -40.98% for 3 months and about 19.80% for the past 30 days.

Last time, the company shocked Wall Street by reporting EPS of $-0.73, smashing the consensus of $-0.86 per share. Revenue for the quarter also did not kill consensus, coming in at $0.1M, compared to the consensus of 0M. Nonetheless, from here on out, earnings per share forecasts for the current quarter are $-0.73. The company is expected to report EPS as high as $0.13 and as low as $-15.12 per share. Similarly, full-year EPS forecasts have ranged between $-0.00 and $0.00. The mean EPS estimate is $-1.00. On the other side, sales forecasts for the current quarter are $0.1M. The stock is expected to report revenue as high as $0.1M and as low as $0M per share. Similarly, full-year sales forecasts have ranged between $14.26M and $0.17M. The mean revenue estimate is $0.99M.

Over the last 5 years, Camber Energy, Inc. has averaged a -17.50% YoY EPS growth rate and a -20.40% revenue growth rate. Analysts are expecting EPS growth rates to be at -365.40% this quarter.

Sell-side analysts also have something to say about this company.

WILL CAMBER ENERGY, INC. (CEI) SURPASS THE EXPECTATIONS THAT ANALYSTS HAVE SET? was last modified: July 10th, 2017 by Rosemary Becker
'Everything works out in the end,,,If it hasn't worked out,,it's not the end'


https://twitter.com/twitter/statuses/957208055766241280
Scroll down for more posts ▼

Top 10 Most Recent News Articles

China Reaffirms Financial Opening-Up, Targets Global Investors

Updated Category News Views 4

A New Stage in China's Financial Opening-Up China's making some serious waves in the financial seas this week, kicking off the Annual Conference of the Financial Street Forum 2026 in Beijing. The big guns from China's financial regulatory bodies are rolling out policies with one clear message: they’re serious about opening up. They're launching pilot initiatives like...

Continue Reading
Advancing Mental Health in NICU Families: 2026 Event Insight

Updated Category News Views 0

Addressing Critical Needs: Hand to Hold's Mission Now, I don't know about you, but when I hear "NICU," my mind goes straight to the intense pressure and emotional rollercoaster that it signifies for families. Hand to Hold, a nonprofit that’s knee-deep in supporting NICU families, isn’t just sitting on their hands. They're hosting a 2026 National NICU Mental Health...

Continue Reading
AppLovin Faces Lawsuit Over AI Claims: Investor Alert

Updated Category News Views 7

AI Promises or Pipedreams? AppLovin Corporation finds itself in a bit of hot water, and if you've got skin in this game, you've probably felt the heat. So, what's stirring the pot? A class action lawsuit against AppLovin (NASDAQ: APP) for allegedly pulling the wool over investors' eyes with overstated claims about their generative AI tool. Class Action: Weighing the...

Continue Reading
MEDITECH and Lifemed AI Join Forces on Healthcare AI

Updated Category News Views 9

Lifemed AI and MEDITECH: A New Chapter in Healthcare You’d think by now the healthcare systems would be catching a break with technology, but here comes another twist. Lifemed AI and MEDITECH have banded together to tackle the notorious issue of claim denials head-on. Picture this: billions squandered every year because of avoidable administrative slip-ups. That's money...

Continue Reading
Agra Energy's Breakthrough: TRL 9 Achieved with SAF

Updated Category News Views 2

Agra Energy Shows the Market Its Cards Agra Energy's hit TRL 9 by turning dairy biogas into Fischer Tropsch Liquid Fuels at their new site in New Franken, Wisconsin. Now, that might sound like just another tech milestone, but let me break it down for you—it's a big moment when a promising technology proves itself in the commercial wild. What's really cooking here?...

Continue Reading
Alaska Air Group's Q3: Facing Headwinds and Strategies

Updated Category News Views 7

Weathering the Q3 Storm Alaska Air Group's third quarter results are in the bag, and let me tell ya, it's a mixed bag of sour lemons and hopeful limes. Reporting a net loss of $147 million or ($1.32) per share ain't the kind of results that plaster smiles on investors' faces. But hey, it's a volatile sector if there ever was one, especially with fuel costs ballooning to a...

Continue Reading
Scrutinizing M&A Deals: VREX, HZO, SYNA Under Fire?

Updated Category News Views 17

Alignment or Deception: The M&A Alarm Bells Investors, strap in, because the world of mergers and acquisitions is lighting up like a pinball machine, and today's spotlight's on Varex Imaging Corporation (NASDAQ: VREX), MarineMax (NYSE: HZO), and Synaptics Incorporated (NASDAQ: SYNA). Halper Sadeh LLC, known for their tenacity in championing shareholder rights, has brought...

Continue Reading
Mili and Egnyte Transform Financial Advice Delivery

Updated Category News Views 0

AI Powers Up Financial Advisors with New Partnership Ah, the grind never ends for those financial advisors, right? Well, here's a nugget that might just lighten their load. Mili and Egnyte are buddying up to merge AI with secure content platforms, aiming to supercharge how advisors handle client documents. Right off the bat, advisors can crank out personalized advice at a...

Continue Reading
Kat Florence Hotels Offers Unique $20K Wine Tastings

Updated Category News Views 7

Luxury Retreat Offering Free Rare Wine Tastings The world of high-end hospitality just got a bit more intoxicating, literally. As of October 20, guests at the Elora luxury retreat, part of the Kat Florence Hotels portfolio, can indulge in some of the most coveted wines on the planet—gratis. That's right, wine aficionados can thank Kat Florence's latest extravagant...

Continue Reading
Heineken Hit with €111M Judgment—A Precedent Set

Updated Category News Views 0

A Brew of Legal Consequences for Heineken If this isn't a financial wake-up call for the brewing giant, I don't know what is. In the latest twist of corporate accountability, the Amsterdam District Court has ordered Heineken and its Greek subsidiary, Athenian Brewery, to cough up a whopping €111 million. And we're not just talking pocket change—this ruling speaks...

Continue Reading

Top 5 Most Recently Viewed Articles

Oxipital AI Partners with Schmalz for Automated Solutions

Updated Category News Views 144

Oxipital AI and Schmalz Strengthen Their Collaboration Oxipital AI, a pioneer in machine vision systems powered by artificial intelligence, is thrilled to announce an exciting step forward in its long-term alliance with Schmalz. This announcement marks Schmalz's entry into Oxipital's Preferred Partner Program, a testament to their strong partnership. Revolutionizing...

Continue Reading
TG Therapeutics Soars with Promising Revenue Projections Ahead

Updated Category News Views 108

Impressive Growth for TG Therapeutics in 2024 TG Therapeutics, Inc. (NASDAQ: TGTX), a leader in innovative treatments for B-cell malignancies and autoimmune diseases, recently revealed a remarkable surge in its shares, which increased by 8%. This impressive rise followed the company’s announcement of preliminary net product revenue for the fourth quarter and the entire...

Continue Reading
Ultra Intelligence & Communications Secures Major Air Force Contract

Updated Category News Views 92

Ultra Intelligence & Communications Secures Major IDIQ Contract Ultra Intelligence & Communications has recently announced that it has been awarded a significant $31.4 million Indefinite Delivery, Indefinite Quantity (IDIQ) contract by the U.S. Air Force. Supporting Joint Air Defense Systems This five-year contract aims to deliver engineering support, help desk services,...

Continue Reading
Rocket Lab's Ascendancy in the Global Space Launch Sector

Updated Category News Views 153

Rocket Lab's Rise in the Aerospace and Defense Sector The positive news keeps flowing for Rocket Lab USA, Inc. (NASDAQ: RKLB), a noteworthy player in the aerospace and defense industry. The momentum began with a significant upgrade from analysts at Cantor Fitzgerald, who raised their price target for the company. Recently, Rocket Lab has also been selected by the European...

Continue Reading
Skeebo Foundation Invests $6.9 Million in Modern Classrooms Project

Updated Category News Views 360

Skeebo Foundation Invests in Education Innovation Modern Classrooms Project, an innovative nonprofit focused on enhancing the teaching and learning experience, has recently announced the receipt of a $6.9 million grant from the Skeebo Foundation. This significant funding aims to optimize and scale their curriculum-aligned math learning solutions, making a positive impact...

Continue Reading